Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France

Author:

Addamiano Maria-Claudia1,Joannès Camille1,Fonquerne Leslie1,Morel Charlotte2,Lauzeille Delphine3,Belkadi Lorène2,Empereur Fabienne3,Grosclaude Pascale4,Bauvin Eric2,Delpierre Cyrille1,Lamy Sébastien4,Durand Marie-Anne1

Affiliation:

1. EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Inserm, Université Toulouse III Paul Sabatier, France.

2. Regional Cancer Network of Occitanie (Onco-Occitanie), Toulouse, France

3. Regional Cancer Network of Pays de la Loire (Onco-PL), Nantes, France

4. Tarn Cancers Registry, Claudius Regaud Institute, Toulouse University Cancer Institute (IUCT-O), Toulouse, France.

Abstract

Abstract Background With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, such as gonadotoxicity. Fertility preservation is becoming increasingly important in cancer management. International recommendations agree on the need to inform patients prior to treatments about the risk of fertility impairment and refer them to specialized centers to discuss fertility preservation. However, the literature reveals suboptimal access to fertility preservation on an international scale, and particularly in France, making information for patients and oncologists a potential lever for action. Our overall goal is to improve access to fertility preservation consultations for women with breast cancer through the development and evaluation of a combined intervention targeting the access and diffusion of information for these patients and brief training for oncologists. Methods Firstly, we will improve existing information tools and create brief training content for oncologists using a qualitative, iterative, user-centred and participatory approach (objective 1). We will then use these tools in a combined intervention to conduct a stepped-wedge cluster randomized trial (objective 2) including 750 women aged 18 to 40 newly treated with chemotherapy for breast cancer at one of the 6 participating centers. As the primary outcome of the trial will be the access to fertility preservation counselling before and after using the combined intervention (brochures and brief training for oncologists), we will compare the rate of fertility preservation consultations between the usual care and intervention phases using linear regression models. Finally, we will analyse our approach using a context-sensitive implementation analysis and provide key elements for transferability to other contexts in France (objective 3). Discussion We expect to observe an increase in access to fertility preservation consultations as a result of the combined intervention. Particular attention will be paid to the effect of this intervention on socially disadvantaged women, who are known to be at greater risk of inappropriate treatment. The user-centred design principles and participatory approaches used to optimize the acceptability, usability and feasibility of the combined intervention will likely enhance its impact, diffusion and sustainability. Trial registration: Registry: ClinicalTrials.gov Trial registration number: 2022-057 Date of registration: 7th September 2023 URL: https://classic.clinicaltrials.gov/ct2/show/NCT05989776 Protocol version: Manuscript based on study protocol version 2.0, 21st may 2023.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3